NCT06083454 2026-03-13
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
University of Iowa
Phase 1 Terminated
University of Iowa
Alliance for Clinical Trials in Oncology
Accuray Incorporated
National Institutes of Health Clinical Center (CC)
AIO-Studien-gGmbH
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)